Detailed answers about OXFORD SUPRAMOLECULAR BIOTECHNOLOGY LIMITED, including incorporation, status, business activity, and accounts information.
When was OXFORD SUPRAMOLECULAR BIOTECHNOLOGY LIMITED founded?
OXFORD SUPRAMOLECULAR BIOTECHNOLOGY LIMITED was officially incorporated on 30 January 2019 and is registered under company number 11796555. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is OXFORD SUPRAMOLECULAR BIOTECHNOLOGY LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of OXFORD SUPRAMOLECULAR BIOTECHNOLOGY LIMITED?
OXFORD SUPRAMOLECULAR BIOTECHNOLOGY LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does OXFORD SUPRAMOLECULAR BIOTECHNOLOGY LIMITED do?
OXFORD SUPRAMOLECULAR BIOTECHNOLOGY LIMITED operates in the following sectors: 21100 - Manufacture of basic pharmaceutical products, 46460 - Wholesale of pharmaceutical goods. These SIC codes provide insight into the company's business activities and industry focus.
What is OXFORD SUPRAMOLECULAR BIOTECHNOLOGY LIMITED's registered address?
The registered office address of OXFORD SUPRAMOLECULAR BIOTECHNOLOGY LIMITED is 15-17 UPPER GEORGE STREET, CONNAUGHT HOUSE, LUTON, UNITED KINGDOM, LU1 2RD. This is the official address filed with Companies House for legal and statutory correspondence.
Is OXFORD SUPRAMOLECULAR BIOTECHNOLOGY LIMITED financially stable?
The most recent accounts for OXFORD SUPRAMOLECULAR BIOTECHNOLOGY LIMITED were made up to 31 January 2025, filed as DORMANT. Next accounts are due by 31 October 2026.